J&J JNJ recently reported new positive data from the phase III MARIPOSA study, which compared the combination of Rybrevant and Lazcluze against AstraZeneca’s AZN Tagrisso in first-line EGFR-mutated ...

Pictet Asset Management boosted its Johnson & Johnson holdings by 12.3%, adding over 155,000 shares in Q4. This raised its ...

Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers ...

Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million in a lawsuit alleging that ...

Johnson & Johnson (JNJ) announced its plans to invest over $55 billion over the next four years in the U.S. to strengthen its ...

J&J JNJ announced plans to invest more than $55 billion in the United States over the next four years to boost manufacturing, R&D and technology in the country. This represents a 25% increase in ...

Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing ...

Congress Wealth Management LLC DE shaved 15.7% off its Johnson & Johnson holdings last quarter, selling over 22,000 shares.